— Know what they know.
Not Investment Advice

NCEL NASDAQ

NewcelX Ltd.
1W: -3.4% 1M: -14.9% 3M: -27.1% YTD: +36.4%
$2.85
-0.06 (-2.06%)
 
Weekly Expected Move ±7.3%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $1.3M mcap · 450000 float · 9.79% daily turnover · Short 11% of daily vol

Balance Sheet Trends

Total Assets
$2M +20.9% ▲
5Y CAGR: +26.2%
Total Liabilities
$827K -92.3% ▼
5Y CAGR: -34.5%
Shareholders Equity
$1M +115.9% ▲
Cash & Investments
$2M +85.5% ▲
5Y CAGR: +49.9%
Total Debt
$0 -100.0% ▼
Net Debt
-$2M -326.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$94K$5M$9M$898K$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$94K$5M$9M$898K$2M
Net Receivables$61K$39K$41K$11K$400K
Inventory-$61K-$39K-$41K$0$0
Other Current Assets$89K$76K$107K$846K$49K
Total Current Assets$197K$6M$9M$2M$2M
Property, Plant & Equip.$0$30K$18K$7K$7K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$68K$0$0$0$0
Other Non-Current Assets$947K$12K$12K$17K$283
Total Non-Current Assets$1M$42K$30K$24K$8K
Total Assets$1M$6M$9M$2M$2M
— Liabilities —
Accounts Payable$4M$2M$2M$5M$515K
Short-Term Debt$2M$0$0$2M$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$57K$0$9K$113K$0
Total Current Liabilities$7M$2M$3M$8M$827K
Long-Term Debt$313K$0$0$0$0
Other Non-Current Liab.$178K$319K$136K$261K$0
Total Non-Current Liabilities$3M$3M$3M$3M$0
Total Liabilities$10M$5M$6M$11M$827K
— Equity —
Common Stock$145K$344K$669K$733K$166K
Retained Earnings-$30M-$42M-$58M-$70M-$74M
Accumulated OCI-$19K-$152K-$51K-$158K$109K
Total Stockholders Equity-$9M$542K$3M-$9M$1M
Total Liabilities & Equity$1M$6M$9M$2M$2M
— Key Metrics —
Total Debt$2M$0$0$2M$0
Net Debt$2M-$5M-$9M$736K-$2M
Total Investments$68K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms